Abstract
The four Scottish university medical genetics centres formed a consortium in 1985 to provide a DNA based service in prenatal diagnosis, carrier detection, and predictive testing for a range of Mendelian disorders. Each centre took sole responsibility for laboratory analyses of an assigned set of disorders, while families continued to be investigated and patients counselled within their own areas. DNA was extracted from relevant tissues in the centre most convenient to the family member and then dispatched to the appropriate laboratory for analysis. Results were interpreted and risks assessed by discussion between laboratory staff and the clinical geneticist in charge of the case. In the first three years of the consortium 92 prenatal diagnoses or exclusion tests were carried out, the majority being for cystic fibrosis (35), Duchenne muscular dystrophy (21), and Huntington's disease (11). Carrier testing was carried out in 271 X linked recessive disorders, the most common indications being Duchenne and Becker muscular dystrophies (198) and haemophilias A and B (48). Predictive testing was attempted in 41 consultants at risk for Huntington's disease, 37 at risk for myotonic dystrophy, and 32 at risk for developing adult polycystic kidney disease. The total of all carrier tests, including those for autosomal recessives, was 543. A consortium or supraregional approach to molecular genetics services has a number of advantages. Constituent laboratories need hold only those probes and enzymes relevant to their assigned disorders and can gain maximum experience with these systems. Scattered families may often be linked into single kinships, thus allowing rapid confirmation of diagnosis when an urgent request is made for a prenatal diagnosis.(ABSTRACT TRUNCATED AT 250 WORDS)
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abbott C. M., McMahon C. J., Whitehouse D. B., Povey S. Prenatal diagnosis of alpha-1-antitrypsin deficiency using polymerase chain reaction. Lancet. 1988 Apr 2;1(8588):763–764. doi: 10.1016/s0140-6736(88)91565-6. [DOI] [PubMed] [Google Scholar]
- Brock D. J., Mennie M., Curtis A., Millan F. A., Barron L., Raeburn J. A., Dinwoodie D., Holloway S., Crosbie A., Wright A. Predictive testing for Huntington's disease with linked DNA markers. Lancet. 1989 Aug 26;2(8661):463–466. doi: 10.1016/s0140-6736(89)92084-9. [DOI] [PubMed] [Google Scholar]
- Harris R., Elles R., Craufurd D., Dodge A., Ivinson A., Hodgkinson K., Mountford R., Schwartz M., Strachan T., Read A. Molecular genetics in the National Health Service in Britain. J Med Genet. 1989 Apr;26(4):219–225. doi: 10.1136/jmg.26.4.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harris R., Elles R., Craufurd D., Dodge A., Ivinson A., Hodgkinson K., Mountford R., Schwartz M., Strachan T., Read A. Molecular genetics in the National Health Service in Britain. J Med Genet. 1989 Apr;26(4):219–225. doi: 10.1136/jmg.26.4.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heeley A. F. Screening for cystic fibrosis. J Pediatr. 1983 Nov;103(5):836–836. doi: 10.1016/s0022-3476(83)80508-3. [DOI] [PubMed] [Google Scholar]
- Lyonnet S., Caillaud C., Rey F., Berthelon M., Frezal J., Rey J., Munnich A. Guthrie cards for detection of point mutations in phenylketonuria. Lancet. 1988 Aug 27;2(8609):507–507. doi: 10.1016/s0140-6736(88)90148-1. [DOI] [PubMed] [Google Scholar]
- McIntosh I., Curtis A., Millan F. A., Brock D. J. Prenatal exclusion testing for Huntington disease using the polymerase chain reaction. Am J Med Genet. 1989 Feb;32(2):274–276. doi: 10.1002/ajmg.1320320232. [DOI] [PubMed] [Google Scholar]
- Millan F. A., Curtis A., Mennie M., Holloway S., Boxer M., Faed M. J., Crawford J. W., Liston W. A., Brock D. J. Prenatal exclusion testing for Huntington's disease: a problem of too much information. J Med Genet. 1989 Feb;26(2):83–85. doi: 10.1136/jmg.26.2.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Williams C., Williamson R., Coutelle C., Loeffler F., Smith J., Ivinson A. Same-day, first-trimester antenatal diagnosis for cystic fibrosis by gene amplification. Lancet. 1988 Jul 9;2(8602):102–103. doi: 10.1016/s0140-6736(88)90031-1. [DOI] [PubMed] [Google Scholar]